P+P advises Odewald Funds on the sale of Oberberg Gruppe to Trilantic Europe

Odewald Funds, alongside other shareholders, sold their stake in the Oberberg Group to Trilantic Europe. The execution of the transaction is still subject to approval by the antitrust authorities.

The Oberberg Group operates nine psychosomatic and psychiatric acute care clinics with approximately 560 beds. P+P previously supported Odewald Funds in their successful buy-and-build strategy, including advice on the acquisition of the Somnia private clinics, the Rhein-Jura Klinik and the Parkklinik Wiesbaden Schlangenbad in Hesse.

P+P advised Odewald Funds on the sale with the following team in all locations:

• Jens Hörmann (partner, M&A, Corporate, Munich)
• Alexander Pupeter (partner, tax, Munich)
• Dr. Tim Kaufhold (counsel, M&A, corporate, Munich)
• Dr. Jens Linde (counsel, financing, Frankfurt)
• Daniel Wiedmann (counsel, antitrust law, Frankfurt)
• Dr. Matthias Werner (senior associate, real estate, Berlin)
• Philipp Kopp (associate, M&A, corporate, Munich)
• Philipp Windeknecht (associate, corporate, Munich)
• Dr. Tim Junginger (associate, M&A, corporate, Munich)
• Thies Jacob (associate, M&A, corporate, Munich)
• Dr. Jesko von Mirbach (associate, M&A, corporate, Munich)
• Benjamin Maciejewski (associate, M&A, corporate, Munich)